Role of tumor markers before or during chemotherapy for digestive neuroendocrine carcinomas as an exploratory analysis of JCOG1213.

Sci Rep · 2026 · PMC13243546 · PMID 41992035

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

In cases of pretreatment ProGRP ≥ 92 pg/ml (upper 75th percentile point), the responder group exhibited a decreasing trend in ProGRP levels at 6 weeks after treatment initiation and an increasing trend at the time of progression.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.